ACA
AURA icon

Acorn Capital Advisors’s Aura Biosciences AURA Stock Holding History

Acorn Capital Advisors’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.6M Buy
929,077
+333,333
+56% +$2.38M 1.8% 12
2026
Q1 		$3.99M Hold
595,744
– – 1.13% 14
2025
Q4 		$3.25M Hold
595,744
– – 1.1% 15
2025
Q3 		$3.68M Hold
595,744
– – 1.87% 13
2025
Q2 		$3.73M Buy
595,744
+5,236
+0.9% +$30.6K 2.44% 13
2025
Q1 		$1.45M Buy
+590,508
New +$4.47M 0.97% 18

Other funds holding AURA

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Acorn Capital Advisors's AURA Position: Q2 2026 in Review

Acorn Capital Advisors increased its Aura Biosciences (AURA) stake by 56% in Q2 2026, buying an estimated $2.38M and bringing the position to 929,077 shares worth $6.6M. The position accounts for 1.8% of the portfolio, ranked #12.

Acorn Capital Advisors first reported a position in AURA in Q1 2025 and has held it in 6 quarters since. 146 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • Acorn Capital Advisors held 929,077 shares of Aura Biosciences worth $6.6M as of Q2 2026.
  • Acorn Capital Advisors bought 333,333 Aura Biosciences shares in Q2 2026, an estimated $2.38M.
  • Aura Biosciences made up 1.8% of Acorn Capital Advisors's portfolio in Q2 2026, its #12 holding.
  • Acorn Capital Advisors first reported a position in Aura Biosciences in Q1 2025 and has held it in 6 quarters since.
  • 146 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on Acorn Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.